Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06940297 · RECRUITING
Trial details
- NCT number
- NCT06940297
- Sponsor
- Mayo Clinic
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-18
- Primary completion
- 2031-08-15
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.